Characteristics and management of SARS-CoV-2 delta variant-induced COVID-19 infections from May to October 2021 in China: post-vaccination infection cases.

Xiang, Boqi; Zhang, Yunhua; Ling, Qiong; Xie, Zhenrong; Li, Na; Wu, Duozhi

Xiang, Boqi; Zhang, Yunhua; Ling, Qiong; Xie, Zhenrong; Li, Na; Wu, Duozhi.

Afiliación

Xiang B; Department of Anesthesiology, Hainan General Hospital Haikou 570311, Hainan, China.
Zhang Y; School of Public Health, Rutgers University New Brunswick, NJ, United States.
Ling Q; Hubei Provincial Hospital of Traditional Chinese Medicine; Clinical Medical College of Hubei University of Chinese Medicine; Hubei Province Academy of Traditional Chinese Medicine Wuhan 430061, China.
Xie Z; Department of Anesthesiology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou, China.
Li N; Department of Anesthesiology, The Seventh Affiliated Hospital of Sun Yat-sen University Shenzhen 518107, China.
Wu D; Department of Anesthesiology, Hainan General Hospital Haikou 570311, Hainan, China.

Am J Transl Res ; 14(6): 3603-3609, 2022.

Article en En | MEDLINE | ID: mdl-35836857

Palabras clave

COVID-19 disease; SARS-CoV-2 delta variant; scientific protective measures; variant B.1.617.2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Transl Res Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google